Outcome After Intestinal Transplantation From Living Versus Deceased Donors: A Propensity-matched Cohort Analysis of the International Intestinal Transplant Registry.
Journal
Annals of surgery
ISSN: 1528-1140
Titre abrégé: Ann Surg
Pays: United States
ID NLM: 0372354
Informations de publication
Date de publication:
01 Nov 2023
01 Nov 2023
Historique:
pubmed:
27
7
2023
medline:
27
7
2023
entrez:
27
7
2023
Statut:
ppublish
Résumé
To describe the worldwide experience with living donation (LD) in intestinal transplantation (ITx) and compare short-term and long-term outcomes to a propensity-matched cohort of deceased donors. ITx is a rare life-saving procedure for patients with complicated intestinal failure (IF). Living donation (LD)-ITx has been performed with success, but no direct comparison with deceased donation (DD) has been performed. The Intestinal Transplant Registry (ITR) was created in 1985 by the Intestinal Transplant Association to capture the worldwide activity and promote center's collaborations. Based on the ITR, 4156 ITx were performed between January 1987 and April 2019, of which 76 (1.8%) were LD, including 5 combined liver-ITx, 7 ITx-colon, and 64 isolated ITx. They were matched with 186 DD-ITx for recipient age/sex, weight, region, IF-cause, retransplant, pretransplant status, ABO compatibility, immunosuppression, and transplant date. Primary endpoints were acute rejection and 1-/5-year patient/graft survival. Most LDs were performed in North America (61%), followed by Asia (29%). The mean recipient age was: 22 years; body mass index: 19kg/m²; and female/male ratio: 1/1.4. Volvulus (N=17) and ischemia (N=17) were the most frequent IF-causes. Fifty-two percent of patients were at home at the time of transplant. One-/5-year patient survival for LD and DD was 74.2/49.8% versus 80.3/48.1%, respectively ( P =0.826). One-/5-year graft survival was 60.3/40.6% versus 69.2/36.1%, respectively ( P =0.956). Acute rejection was diagnosed in 47% of LD versus 51% of DD ( P =0.723). Worldwide, LD-ITx has been rarely performed. This retrospective matched ITR analysis revealed no difference in rejection and in patient/graft survival between LD and DD-ITx.
Sections du résumé
OBJECTIVE
OBJECTIVE
To describe the worldwide experience with living donation (LD) in intestinal transplantation (ITx) and compare short-term and long-term outcomes to a propensity-matched cohort of deceased donors.
BACKGROUND
BACKGROUND
ITx is a rare life-saving procedure for patients with complicated intestinal failure (IF). Living donation (LD)-ITx has been performed with success, but no direct comparison with deceased donation (DD) has been performed. The Intestinal Transplant Registry (ITR) was created in 1985 by the Intestinal Transplant Association to capture the worldwide activity and promote center's collaborations.
METHODS
METHODS
Based on the ITR, 4156 ITx were performed between January 1987 and April 2019, of which 76 (1.8%) were LD, including 5 combined liver-ITx, 7 ITx-colon, and 64 isolated ITx. They were matched with 186 DD-ITx for recipient age/sex, weight, region, IF-cause, retransplant, pretransplant status, ABO compatibility, immunosuppression, and transplant date. Primary endpoints were acute rejection and 1-/5-year patient/graft survival.
RESULTS
RESULTS
Most LDs were performed in North America (61%), followed by Asia (29%). The mean recipient age was: 22 years; body mass index: 19kg/m²; and female/male ratio: 1/1.4. Volvulus (N=17) and ischemia (N=17) were the most frequent IF-causes. Fifty-two percent of patients were at home at the time of transplant. One-/5-year patient survival for LD and DD was 74.2/49.8% versus 80.3/48.1%, respectively ( P =0.826). One-/5-year graft survival was 60.3/40.6% versus 69.2/36.1%, respectively ( P =0.956). Acute rejection was diagnosed in 47% of LD versus 51% of DD ( P =0.723).
CONCLUSION
CONCLUSIONS
Worldwide, LD-ITx has been rarely performed. This retrospective matched ITR analysis revealed no difference in rejection and in patient/graft survival between LD and DD-ITx.
Identifiants
pubmed: 37497671
doi: 10.1097/SLA.0000000000006045
pii: 00000658-202311000-00023
pmc: PMC10549910
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
807-814Informations de copyright
Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc.
Références
Mazariegos GV, Abu-Elmagd K, Jaffe R, et al. Graft versus host disease in intestinal transplantation. Am J Transplant. 2004;4:1459–1465.
Garcia-Roca R, Tzvetanov IG, Jeon H, et al. Successful living donor intestinal transplantation in cross-match positive recipients: Initial experience. World J Gastrointest Surg. 2016;8:101–105.
Clarysse M, Canovai E, Vanuytsel T, et al. Current state of adult intestinal transplantation in Europe. Curr Opin Organ Transplant. 2020;25:176–182.
Tzvetanov IG, Tulla KA, D’Amico G, et al. Living donor intestinal transplantation. Gastroenterol Clin North Am. 2018;47:369–380.
Gruessner R, Gruessner A. Solid-organ Transplants from living donors: Cumulative United States Experience on 140,156 living donor transplants over 28 years. Transplant Proc. 2018;50:3025–3035.
Gruessner RW, Sharp HL. Living-related intestinal transplantation: first report of a standardized surgical technique. Transplantation. 1997;64:1605–1607.
Barr ML, Belghiti J, Villamil FG, et al. A report of the Vancouver Forum on the care of the live organ donor: lung, liver, pancreas, and intestine data and medical guidelines. Transplantation. 2006;81:1373–1385.
Gruessner RWG. 25 years of a standardized technique for living donor intestinal transplantation: A systematic review. Transplant Proc. 2022;54:1944–1953.
Grant D, Abu-Elmagd K, Mazariegos G, et al. Intestinal Transplant Registry Report: Global Activity and Trends. Am J Transpl. 2015;15:210–219.
Deterling R. Comment on living donor intestinal transplantation. In: Alican F, Hardy JD, Cayirli M, et al. Intestinal transplantation Laboratory experience and report of a clinical case. Am J Surg. 1971;121:150–159
Alican F, Hardy JD, Cayirli M, et al. Intestinal transplantation: laboratory experience and report of a clinical case. Am J Surg. 1971;121:150–159.
Gruessner R Benedetti E, Gruessner R. History of living donor intestinal transplantation. Living donor organ transplantation. McGrawHill, New York; 2008:678–684.
Margreiter R. The history of intestinal transplantation. Transplant Rev. 1997;11:9–21.
Fortner JG, Sichuk G, Litwin SD, et al. Immunological responses to an intestinal allograft with HL-A-identical donor-recipient. Transplantation. 1972;14:531–535.
Deltz E, Schroeder P, Gebhardt H, et al. First successful clinical small intestine transplantation: tactics and surgical technic. Chirurg. 1989;60:235–239.
Panaro F, Testa G, Balakrishnan N, et al. Living related small bowel transplantation in children: 3-dimensional computed tomography donor evaluation. Pediatr Transplant. 2004;8:65–70.
Jao W, Sileri P, Holaysan J, et al. Morphologic adaptation following segmental living related intestinal transplantation. Transplant Proc. 2002;34:924.
Porubsky MTG, John E, Holterman M, et al. Pattern of growth after pediatric living-donor small bowel transplantation. PediatrTransplantation. 2006;10:701–706.
Kaufman SS, Avitzur Y, Beath SV, et al. New insights into the indications for intestinal transplantation: consensus in the year 2019. Transplantation. 2020;104:937–946.
Burghardt KM, Wales PW, de Silva N, et al. Pediatric intestinal transplant listing criteria - a call for a change in the new era of intestinal failure outcomes. Am J Transplant. 2015 Jun;15:1674–1681.
Benedetti E, Baum C, Cicalese L, et al. Progressive functional adaptation of segmental bowel graft from living related donor. Transplantation. 2001;71:569–571.
Testa G, Holterman M, John E, et al. Combined living donor liver/small bowel transplantation. Transplantation. 2005;79:1401–1404.
Gangemi A, Tzvetanov IG, Beatty E, et al. Lessons Learned in Pediatric Small Bowel and Liver Transplantation From Living-Related Donors. Transplantation. 2009;87:1027–1030.
Benedetti E, Holterman M, Asolati M, et al. Living related segmental bowel transplantation: from experimental to standardized procedure. Ann Surg. 2006;244:694–699.
Wu G, Liu C, Zhou X, et al. Living donor intestinal transplantation: recipient outcomes. Ann Surg. 2022;276:444–449.
Abu-Elmagd KM, Costa G, Bond GJ, et al. Five hundred intestinal and multivisceral transplantations at a single center: major advances with new challenges. Ann Surg. 2009;250:567–581.
Testa G, Holterman M, Abcarian H, et al. Simultaneous or sequential combined living donor-intestine transplantation in children. Transplantation. 2008;85:713–717.
Tzvetanov IG, Oberholzer J, Benedetti E. Current status of living donor small bowel transplantation. Curr Opin Organ Transplant. 2010;15:346–348.
Gondolesi G, Fauda M. Technical refinements in small bowel transplantation. Curr Opin Organ Transplant. 2008;13:259–265.
Darius T, Monbaliu D, Aerts R, et al. Living related intestinal transplantation for Churg-Strauss syndrome: a case report. Transplant Proc. 2010;42:4423–4424.
Ceulemans LJ, Deferm NP, Miserez M, et al. The role of osmotic self-inflatable tissue expanders in intestinal transplant candidates. Transplant Rev (Orlando). 2016;30:212–217.
Morris JA, Johnson DL, Rimmer DL, et al. Identical-twin small bowel for desmoid tumor. Lancet. 1995;345:1577–1578.
Calne RY, Friend PJ, Middleton S, et al. Intestinal transplant between two of identical triplets. Lancet. 1997;350:1077–1078.
Morel P, Kadry Z, Charbonnet P, et al. Paediatric living related intestinal transplantation between two monozygotic twins: a 1-year follow-up. Lancet. 2000;355:723–724.
Schena S, Testa G, Setty S, et al. Successful identical-twin living donor small bowel transplant for necrotizing enterovasculitis secondary to Churg-Strauss syndrome. Transpl Int. 2006;19:594–597.
Asolati M, Testa G, Gangemi A, et al. ‘Prope’ tolerance in a noncompliant living related small bowel transplant recipient after severe rejection. Transplantation. 2007;83:77–79.
Wu G, Zhao Q, Wang M, et al. Identical twin small-bowel transplantation without maintenance immunosuppression: a 5-year follow-up and literature review. Transplant Direct. 2018;4:374.
Hibi T, Chen Y, Kim JI, et al. Current status of intestinal transplantation in East Asia. Curr Opin Organ Transplant. 2020;25:165–168.
Abu-Elmagd KM, Armanyous SR, Fujiki M, et al. Management of five hundred patients with gut failure at a single center: surgical innovation versus transplantation with a novel predictive model. Ann Surg. 2019;270:656–674.
Verbiest A, Wauters L, Vanuytsel T. Enterohormone therapy for short bowel syndrome. Curr Opin Endocrinol Diabetes Obes. 2022;29:207–218.
Rutter CS, Russell NK, Sharkey LM, et al. Decline in renal function following intestinal transplant: is the die cast at 3 months? Clin Transplant. 2021;35:e14249.
Wang P, Yang J, Zhang Y, et al. Risk factors for renal impairment in adult patients with short bowel syndrome. Front Nutr. 2021;7:618758.
Tzakis AG, Gruessner RWG. Future of living-related small bowel transplantation in children. Pediatr Transpl. 1998;2:1–2.
Clarysse M, Dubois A, Vanuytsel T, et al. Potential options to expand the intestinal donor pool: a comprehensive review. Curr Opin Organ Transplant. 2022;27:106–111.
Ji G, Chu D, Wang W, Dong G. The safety of donor in living donor small bowel transplantation: an analysis of four cases. Clin Transplant. 2009;23:761–764.
Testa G, Panara F, Schena S, et al. Living related small bowel transplantation: donor surgical technique. Ann Surg. 2004;240:779–784.
Ghafari J, Tzvetanov I, Spaggiari M, et al. The effect of small bowel living donation on donor lipid profile. Transpl Int. 2012;25:19–20.
Wu G, Liu C, Zhou X, et al. Short- and long-term complications after living donor ileal resection. Am J Transplant. 2022;22:3053–3060.